Kendra Vanness Physical Therapist Medicare: Medicare Enrolled Practice Location: 1720 Central Ave E, Hampton, IA 50441 Phone: 641-456-5034 |
Trina Stone, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1720 Central Ave E, Hampton, IA 50441 Phone: 641-456-5034 Fax: 641-456-5801 |
Ian Malaby, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1720 Central Ave E, Hampton, IA 50441 Phone: 641-456-5034 |
Keith Wayne Wrich, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1720 Central Ave E, Hampton, IA 50441 Phone: 641-456-5034 Fax: 641-456-5801 |
News Archive
The US Food and Drug Administration has granted marketing approval to GlaxoSmithKline's new type 2 diabetes drug, branded Tanzeum in the US and Eperzan in Europe, which uses Novozymes' Veltis technology to achieve an extended half-life that means patients are only required to inject their medication once a week.
Dialysis Patient Citizens today praised the Senate Insurance and Labor Committee for unanimously passing legislation – S.B. 316 – which will increase patient access to life-saving dialysis care or transplant medications. Dialysis patients attending yesterday's hearing encouraged lawmakers to support the bill which, if enacted, would greatly help approximately 2,000 Georgians suffering from kidney failure who are having difficulty accessing health insurance. Twenty-nine states across the country have enacted this popular legislation that is widely embraced by patients, family members and taxpayers.
Multiple myeloma (MM) is a hematological cancer that frequently acquires resistance to chemotherapeutic drugs. Additionally, many patients experience disease relapse, but these patients are difficult to treat as the cancer is often resistant to the previous treatment regimen.
Experts at an American Society of Tropical Medicine and Hygiene meeting this week said that resistance to the best available drug to treat malaria "is more widespread in Southeast Asia than previously reported," Science News/Wired Science reports. Researchers have been monitoring drug resistance along the Thailand-Cambodia border where patients taking artemisinin combination therapy - the most potent treatment for malaria - have been clearing the parasite from their bodies more slowly.
Use of estrogen therapy is associated with an increased risk of developing kidney stones in postmenopausal women, according to a report in the October 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 2 days ago